RICERCA ITALIANA     

FIRB simili:

• 1 - Sviluppo di molecole innovative in grado di curare malattie neurodegenerative e neuroinfiammatorie.
• 2 - Meccanismi molecolari della morte cellulare e loro implicazione in patologia umana
• 3 - Riconoscimento molecolare e funzionalità cellulare
• 4 - Identificazione e validazione di meccanismi genetico-molecolari coinvolti nel trasporto tubulare renale del sodio nell'ipertensione e nelle sue complicanze d'organo.
• 5 - MALATTIE NEURODEGENERATIVE COME CONSEGUENZA DI UN ALTERATO PROCESSAMENTO DI PROTEINE NEURONALI. MODELLI ANIMALI E DI COLTURE CELLULARI IN VITRO.
• 6 - Il sistema di trasduzione del segnale Ca2+: dalle molecole alle funzioni
• 7 - Identificazione di profili genomici nucleo-mitocondriali nella patogenesi di malattie comuni età-associate. Implicazioni diagnostiche e terapeutiche.
• 8 - Modelli transgenici per malattie ad eziologia complessa
• 9 - Misfolding di proteine e patologie umane: studio della conversione patologica di proteine globulari in aggregati fibrillari e sviluppo di farmaci che inibiscano i processi di misfolding e aggregazione
• 10 - Il riconoscimento molecolare nelle interazioni proteina-ligando, proteina-proteina e proteina superficie: sviluppo di approcci sperimentali e computazionali integrati per lo studio di sistemi di interesse farmaceutico

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze biologiche
  • BIOLOGIA MOLECOLARE
• Area scientifico disciplinare: Scienze mediche
  • GENETICA MEDICA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)
  • METALLURGY OF IRON
    • MANUFACTURE OF IRON OR STEEL (preliminary treatment of ferrous ores or scrap C22B1/00; electric heating H05B)

Classificazione geografica

• Regione: Lombardia

Bibliografia

Andrews NC. Iron homeostasis: insights from genetics and animal models. Nat Rev Genet. 2000 Dec;1(3):208-17.
Bacon BR. (2001) Hemochromatosis: diagnosis and management.Gastroenterology. 120(3):718-25.
Beutler, E.; Gelbart, T.; Lee, P.; Trevino, R.; Fernandez, M. A.; Fairbanks, V. F. (2000)Molecular characterization of a case of atransferrinemia. Blood 96: 4071-4074.
Cairo, G. and Pietrangelo, A. (2000) Iron regulatory proteins in pathobiology. Biochem J 352 Pt 2:241-50. Review.
Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M, Majorano N, Totaro A, Gasparini P. (2000) The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet. 25(1):14-5.,
Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, et al. (1996) Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science.271(5254):1423-7.
Cazzola M, Cerani P, Rovati A, Iannone A, Claudiani G, Bergamaschi G.(1998) Juvenile genetic hemochromatosis is clinically and genetically distinct from the classical HLA-related disorder. Blood. 1998 Oct 15;92(8):2979-81.
Connor JR, Menzies SL, Burdo JR, Boyer PJ. .(2001) Iron and iron management proteins in neurobiology. Pediatr Neurol 25(2):118-29.
Corsi,B., Levi,S., Cozzi,A., Corti,A., Altimare,D., Albertini,A., and Arosio,P. (1999). Overexpression of the hereditary hemochromatosis protein, HFE, in HeLa cells induces and iron-deficient phenotype. FEBS Lett. 460, 149-152.
Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus GS, Pinkus JL, Kingsley PD, Palis J, Fleming MD, Andrews NC, Zon LI. (2000) Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 17;403(6771):776-81.
Fargion S, Stazi MA, Fracanzani AL, Mattioli M, Sampietro M, Tavazzi D, Bertelli C, Patriarca V, Mariani C, Fiorelli G. (2001) Mutations in the hfe gene and their interaction with exogenous risk factors in hepatocellular carcinoma. Blood ;27(2):505-11.
Fleming, M. D.; Trenor, C. C., III; Su, M. A.; Foernzler, D.; Beier, D. R.; Dietrich, W. F.; Andrews, N.C. : Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nature Genet. 16: 383-386, 1997
Fracanzani AL, Conte D, Fraquelli M, Taioli E, Mattioli M, Losco A, Fargion S (2001). Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease.Hepatology.33(3):647-51.
Girelli D, Corrocher R, Bisceglia L, Olivieri O, Zelante L, Panozzo G, Gasparini P. Hereditary hyperferritinemia-cataract syndrome caused by a 29-base pair deletion in the iron responsive element of ferritin L-subunit gene. Blood. 1997 Sep 1;90(5):2084-8.
Harris ZL, Takahashi Y, Miyahma H et al. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Nat Acad Sci USA 1995; 92: 2539-2543
Harrison,P.M. and Arosio,P. (1996). The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta 1275, 161-203.
Iwai,K., Klausner,R.D., & Rouault,T.A. (1995) Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2. EMBO J., 14, 5350-5357.
Kispal,G., Csere,P., Prohl,C., & Lill,R. (1999) The mitochondrial proteins Atm1p and Nfs1p are essential for biogenesis of cytosolic Fe/S proteins. EMBO J., 18, 3981-3989.
LaVaute, T.; Smith, S.; Cooperman, S.; Iwai, K.; Land, W.; Meyron-Holtz, E.; Drake, S. K.; Miller, G.; Abu-Asab, M.; Tsokos, M.; Switzer, R., III; Grinberg, A.; Love, P.; Tresser, N.; Rouault, T. (2001) A. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nature Genet. 27: 209-214
Levi S, Corsi B, Bosisio M, Invernizzi R, Volz A, Sanford D, Arosio P, Drysdale J. (2001) A human mitochondrial ferritin encoded by an intronless gene. J Biol Chem 270; (27) 24437-24440.
Levi,S., Girelli,D., Perrone,F., Pasti,M., Beaumont,C., Corrocher,R., Albertini,A., and Arosio,P. (1998). Analysis of ferritins in lymphoblastoid cell lines and in the lens of subjects with hereditary hyperferritinemia-cataract syndrome. Blood 91, 4180-4187.
Lill,R., Diekert,K., Kaut,A., Lange,H., Pelzer,W., Prohl,C., & Kispal,G. (1999) The essential role of mitochondria in the biogenesis of cellular iron- sulfur proteins. Biol.Chem., 380, 1157-1166.
May,A. & Bishop,D.F. (1998) The molecular biology and pyridoxine responsiveness of X-linked sideroblastic anaemia. Haematologica, 83, 56-70.
Minotti, G., Mancuso C, Frustaci A, Mordente A, Santini SA, Calafiore AM, Liberi G, Gentiloni N. (1996) Paradoxical inhibition of cardiac lipid peroxidation in cancer patients treated with doxorubicin. Pharmacologic and molecular reappraisal of anthracycline cardiotoxicity. J Clin Invest.. 98:650-661.
Minotti, G, Recalcati S, Mordente A, Liberi G, Calafiore AM, Mancuso C, Preziosi P, Cairo G. (1998) The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein-1 in cytosolic fractions from human myocardium. FASEB J. 12: 541-552.
Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, Trenor CC, Gasparini P, Andrews NC, Pietrangelo A. (2001) Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest. 108(4):619-23.
Palau,F. (2001) Friedreich's ataxia and frataxin: Molecular genetics, evolution and pathogenesis (Review). Int.J.Mol.Med., 7, 581-589.
Pietrangelo A, Montosi G, Totaro A, Garuti C, Conte D, Cassanelli S, Fraquelli M, Sardini C, Vasta F, Gasparini P (1999). Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene. N Engl J Med. 341(10):725-32.
Piperno A, Sampietro M, Pietrangelo A, Arosio C, Lupica L, Montosi G, Vergani A, Fraquelli M, Girelli D, Pasquero P, Roetto A, Gasparini P, Fargion S, Conte D, Camaschella C (1998). Heterogeneity of hemochromatosis in Italy. Gastroenterology 114(5):996-1002.
Ponka,P. (1999) Cellular iron metabolism. Kidney Int.Suppl, 69, S2-11.
Puccio H, Simon D, Cossee M, Criqui-Filipe P, Tiziano F, Melki J, Hindelang C, et al. (2001)Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet 27(2):181-6.
Recalcati, S, Pometta R, Levi S, Conte D, Cairo G. (1998) Response of monocyte iron regulatory protein activity to inflammation: abnormal behavior in genetic hemochromatosis. Blood, 91: 1059-1066
Roetto A, Totaro A, Cazzola M, Cicilano M, Bosio S, D'Ascola G, Carella M, Zelante L, Kelly AL, Cox TM, Gasparini P, Camaschella C. (1999) Juvenile hemochromatosis locus maps to chromosome 1q. Am J Hum Genet.64(5):1388-93.
Roetto A, Totaro A, Piperno A, Piga A, Longo F, Garozzo G, Cali A, De Gobbi M, Gasparini P, Camaschella C (2001). New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood 97(9):2555-60.
Rouault, T.A. and Klausner, R.D. (1997) Regulation of iron metabolism in eukaryotes.Curr Top Cell Regul. 35:1-19. Review. .
Tacchini, L., Recalcati S, Bernelli-Zazzera A, Cairo G. (1997) Induction of ferritin synthesis in ischemic-reperfused rat liver: analysis of the molecular mechanisms..Gastroenterology 113: 946-953.
Vulpe, CD.; Kuo, YM.; Murphy, TL.; Cowley, L.; Askwith, C.; Libina, N.; Gitschier, J.; Anderson, G.J. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nature Genet. 21: 195-199, 1999
Wong A, Yang J, Cavadini P, Gellera C, Lonnerdal B, Taroni F, Cortopassi G. (1999) The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum Mol Genet 8(3):425-30.

Parole Chiave

emocromatosi; anemia; atassia; tumore; ferritina; danno ossidativo